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Durhnm. Norrh Corobu 
lo a training samplt of 1,136 patients (studied between 1980 
and 19841, two independent prediiton of spasm were found by 
using multivariate analysis: the amount of visible oxnwy artery 
disease on Le coronary angiogram <p < O.wOI) and a smoking 
Coronary va~osparm has been proposed as a major cause of 
acute cardiac events. including myocxdial infarctton and 
sudden cardiac death (l-4). and it is presumed to be a 
significan! cotnprnent of the palhophysiology of ~ngmal 
symptoms in many patients (5). The only way to noninva- 
sivcly recognize patients who are likely to have coronary 
spasm is to document the transient ST segment elevation 
associated with Prinzmetal’s variant angina. Because such 
documentation mzy be elusive. cardiologists have explored 
the use of provocative testing with ergonovine n&ate 
during diagnostic cxdia; fathetenzation to fxibtate ,‘Iis 
process (6.7). Although limited experience has been gained 
with provocative testing in :he presence of significant fixed 
ccronary artery disease (8). the general consensus has brrn 
that testing is safest in patients with suspected symptoms of 
coronary dtsease but no significant coronary stenosis at 
angiogmphy (9). 
Over the lirst decade, 3,447 patients with insignificant 
~ownarv disease or andomtmhicallv dormal coronary artw 
ies hav; undergone p~v&&ve e&wine testin; at the 
cardiac carh~wization labaratorv a Duke Universitv Med- 
ical Center. This report dercribe~ this experience, i&ding 
test results and coq~ications. and identifies the clinical and 




Study patiettts. The study group was selected from 17,327 
consecutive Datients who underwent nonems~ency cardix 
cathetcriratiun at Duke Univenity Medical C&te;between 
IWO and l9R9. Durine the studv oeiiod. er!zoonovine testing 
was performed routinely by mok’mgiographen if the cow 
nary angiogram failed to identify significant coronary ancry 
disease. Of the 4,427 patients wttb normal coronary artcrirs 
or insignificant co~nary disease (~-50% visual focal narrow- 
ing). 3,447 (78%) underwent ergonovine testing and formed 
the studv srotm. The main reasun for not performing an 
ergonov~ne~test’was ongoing nitroglycerin x calcium chan- 
VI b!crker !herapy at the time of the diagnostic m!heteri;l- 
tion. In some cases. patients were returned to the c?theter- 
ization laboratory when these agents had been discontinued, 
and ergottwine testing was then performed in a ~eparale 
setting. Patie.tts were excluded from analysis if documeved 
Prinzmetal angina wan prewt. Other exclusion5 included 
significant (r75% visual focrl carrowing) corcxary anery 
disease, global wall motion abnormalities on rhe ventriculo- 
gram. significant mitral regurgitation (z?+i, valvular heart 
disease. congeni?al heart disease, previous coronary artery 
bypass grafting, previous pcrrutaneous coronary angio- 
plasly and systolic blood pressure 2190 mm Hg. 
Ergono~ine trst, coronary angiography and ventriculogra- 
phy. The ergonovine test was always performed in a stan- 
dardized fashion at the e,d ofthi. diagnostic catheterization 
study DOWP ofO.nq, 0.1 rnd 0.15 mg nfergonovine mateate 
were given mtravenousl~ m succes&n ai 3-min intervals. 
Systemic blood pressure. thrx elcct.ocardiographic (ECGI 
leads and symptoms were monitored continuously. Angiog- 
rnphy WY repeated at the conclution of the protocol or if 
aneinal svmntoms or ECG chances develooed. A rmsitive 
te,t r&t has defined as &rO focal &oui~g of a 
coronary artery. Diffuse spasm WE not regarded as a 
positive test result. nor were symptoms or ECG change, 
alone unless accompanied by angiographic documentation of 
coronary spasm. 
Left venrric&vup$ was performed in a standard man- 
ncr in either the single-plane (33%) or, more commonly, the 
biplane (67%~ mode. Regional wall motion was visually 
graded as normal, hypakinetic. akinetic. dyskirac or aneu- 
rysmal. For the purposes of this study, wall motion abnor- 
malities of any revcrity were gmuped together 8s abnormal 
wall motion. Coronary anatomy was visually defined as 
normal (no lesions). havine minor irreeularities. havine a 
25% lesion (1% to iS% s&is). a SO%?esion (26% to 5i% 
stenosis). a 75% I-:sion (51% to 75% srenosis1. a 95% lesion 
(76% to 95% stenosis), a 99% lesion (96% to 95% stenosis) or 
total occlusion. Insignificant disease was implied if the lesion 
was reported as ~50%. 
Data collection and analysis. Demographic. clinical and 
catheterization variables were collected prospectively by the 
Duke Cardiovascular Disease Databank, as described previ- 
ously (IO). A description ofthe patient’s symptoms and ECG 
changes dunng ergonovine testing and the overall interpre- 
tation of the test were entered km the data base dong with 
routine cardiac catheterization information. One of us re- 
viewed the clinical information and tine film of all patients 
with a posihve ergonovme test result. 
To iden@ the majx predicrors ofu pair& ergonovine 
resr resrrlr, the study group of 3,447 patients VW separated 
chronologically into two groupa. A &imng sarnpte consist- 
ingof1.136patientr studied between t980and 1984 war used 
to identify the best predictor variables. and a ~a! crour) 
consisting vf 2.31 I patients studied betwcen 1985 and 198’9 
was used to vahdate those findines. The binarv loeistic 
regression model (I I j was used to identify univariate predic- 
tor$ of spnsm ir. the training semple. Significant individual 
variables were then Cniered into n stepwise logislic regres- 
sion modei to identify the best bet of independent predictors 
of a positive ergonovine test. 
regression model tl,at is most appropriate~~o use when 
assessing the probability ofan outcome (raneimfrom 0 to 1). 
This model examines the relation between a set of charac- 
teristics (for this study, the independent variabies shwn in 
Tables I to 3) and the risk or probability of a birary outcome 
(spasm or no spasm. the dependent variable). 
The final logistic model developed in rhe rraining sompl~ 
is then tested in the separate vahdation sample of patient?. 
Two aspects of the model’s performance are evaluated in 
this new sample (Hawell FE 11. Lee K, unpublished data): 
!hc reliability of model wedictions. or how well medicdons 
agree with the observei prevalence of ergat.ind&ed vaso- 
spasm; and the discriminrdion of predictions. assessing the 
extent to which the model makes higher predictions in the 
patients with a pusitive test re!;ult and lower predictions in 
those with a negative test result. Reliability is tested in the 
validation sample by using the logistic calibration model 
(Harrell FE Jr, Lee K, unpublished data). With this test, a 
nonsignificant p value indicates a good fit between model 
Table 2. Basetir.e Aneinal Hislow of the TraininK Sam& 
predictions and observed lest outcomes. Discrimination is 
measured by using the area uuder the receiver-operating 
characteristic urve (12). A receiver-operating characteristic 
axa of@.5 icdicatrs no dircrimi&on bettr: than chaxe; ao 
wea of 1 indicates a perfect model. 
Results 
Complkatiom. Of ihe 3,443 patients with normal or 
insignificant coronary anmy disease who underwent provoc- 
ative testing with ergonovine between 1980 and 1989, 125 
patients (4%) had a positive test result. Complications during 
or after ergonovine testing occurred in 1 Ipatients (0.03%) in 
the total study group. Myocardial infarction occurred in four 
oatients (0.01%) and ventricular tachvcardia or tibtillation in 
&en patients (0.02%). No procedure-related eath of- 
curred. These results compare favorably with those of a 
recent analysis (13) that revealed an incidence rate of O.Olt% 
for myocardial infarction and of 0.05% for ventricular tachy- 
cardia and fibrillation in the total group of patients who have 
undergone cardiac catheterization at our center. 
Training rnmpte chararterktics. 3aseline ,haracteristics 
of the 1.136 training sample patients were analyzed to 
determine whether clinical or Ggiagraphic factors could be 
used to identify the patients most likely to have a positive 
crgonovine test result (Table I). A history of smoking was 
the clinical variable found to be most strongly predictive of 
a positive test result. Of the 44 patients with coronary 
spasm, 35 (80%) were smokers compared with 512 (47%) of 
the I.092 patients without spasm (p < O.ooOl). There also 
was a preponderance oi’men in the proup with a positive test 
result (64% vs. 44%. p = 0.012). Other variables including 
age, hypet tension, diabetes mellitus, hyperlipidemia, family 
history and a history ofmyocardial infarction did not predict 
a positive test. Nine of-the descriptors from the &&al 
history from this set of patients without significant coronary 
artery disease in the traioing samp!e (Table 2) were predk- 
tive of a positive test. 
Baseline carkererizarion data in the mining sample (To- 
bfe 3) demonstrated that 55% of the patients with a positive 
ergonovine test result had a 25% t(r 50% coronary lumen 
diameter stenosis compared with 21% of patients with a 
negative test result (p 4 0.0001). Furthermore, some aboor- 
mality of left vestricu!ar wt! motion was evident in lb% of 
the patients wdh a positive result vexsx SI of!hcx with a 
negative rexdt (p = 0.076). By using the logjstic mu:r;$e 
regression model with stepwise variable selections, two 
independent predictcn of spasm were identified in the 
training sample (Table 4): maximal corooary stenosis present 
(2 = 27. P < O.C@OI) and smoking history d = II, p = 
0 OO!). 
Valldatioo sample. In the separate validation sample, 
2.311 patients were tested between 1985 and 1939 and the 
statistical test for unreliability of the model was not signiii- 
cant C,$ = 3.8 with 2 df, p = 0.15). This result indicates that 
there was a gwd fit io this new sample &tween model 
predictions and observed test outcomes. The area under the 
receiver-operating characteristic urve for the model predic- 
tions in the val&ion sample was 0.732. which was only 
slightly lower tban that observed in the :raining sample 
(xeeiver-operatisg characteristic urve area = 0.756). indi- 
cating cornpa-db:.: discrimination by the model in the two 
groups. 
To illustrate the utility of rkis madcl in a mnre clinically 
accessible format, we derived an illustrative risk score by 
assigning patients 1 point fm a coronary stenosis of *50% 
and 1 point for a history of smoking (score range 0 to 2). 
Scores were then ca!culated fw each patient in the training 
and validation samples (Fig. 1). One percent of patienls in 
both samples with a score of0 had a positive ergonovine test 
:esult. With a score of I, 4% of the tmining sample and 3% 
of the validation sample had a positive test result. In the 
patients with a score of 2, Ills of the training sample and 
10% ofthe validation sample had aposItive test result. When 
the full logistic model was applied to the patients in the 
validation sample, defining a high risk group a~ those with a 
model prediction of a positive !es! restlit ~5% it identified a 
subset of 4&l parienlr (17% of the validation sample) witb a 
10% rate of a positive test result compared with a rate of 2% 
in the remaining I.911 patients. 
This rtudy IS the first :o use mullwariate analysis to 
identify the major independent predmtors of d p0siti.c 
ergonovine test in patients without significant coronary 
artery disease. This slGdy a/so validates those predicmrs in 
an independent prospective cohort of patients. These results 
should prow useful to angiographers and clinicians who 
consider using provocative testing for coronary vasospasm 
appropriate but are concerned about the overall ow yield of 
the test. 
Provocative tes:ing with ergonwine. This test has de 
creased in popularity. partly because m)ocardial infarction 
and death have been reported io a few instances and because 
it is unclear how mutt, ihe test adds to a careful history and 
ambulatory ECG monitoring (14). A dilemma arises in the 
group ofpatients who have chest pain suace&c ofcoronary 
ariery d&x sigotlicant enough io war&t angiography bit 
who do not have wfficient hemoEynamically signiiicact 
coronary obstructions or other findings at the time of angi- 
ography to explain the symptoms. Although ergonovine 
prcvocatwe testing is both a sensitive and D specific method 
for documentarton of coronary artery spasm in selected 
patients (that is, patients with ECG-documented Prinzmet- 
al’s angma and significant fixed coronary artery disease), its 
diagnostic yield is much lower in other groups (7,8.15,16). 
The low incidence of complications of ergoravine tesiing in 
this stody is in accordance with that of previou. atudirs 
(8,16.W of patients without significant fixed coronary artery 
disease. 
History of smoking and SUW coronarv artery stenosis as 
predicton ui a p&sit& test. Multivariate anal& of both 
clinical and catheterization.derived variables identified a 
history of smoking and the presence of 50% (defined as 
between 21% and 51%) stenosis as markers of patients most 
likely to have a positive crgonovinc test result. A score 
based on the presence of these variables identified a scbset 
of patients with a two- to threefold greater likelihood of 
ergoonovine-induced spasm. Although the cause of coronary 
spasm is uncertain, previous studies @.17-20) have sug- 
@cd that both smoking and the presence ofatherosclerotic 
coronary artery disease are associated with this process. 
Previous comparisons of risk factors in palients with variant 
angma and normal or near normal coronary arteties and 
prrien:s with tixcd coronary swry disease suggest thnt 
cigarette smoking may play a role in coronary axry disease 
independent of atherosclerosis and may possiblv favor cor- 
onary artery spasm (17). Several mechanisms~ have txcn 
prooooed (20-25) to exolain the effects of smokine o,t mtzirm 
pectoris: catecholamine release due to the effects of o&o. 
tine. decreased myocardial oxygen delivery due t(. ittbslation 
of carbon monoxide and activatian of platelet aggregation. 
Smoking at the time of cardiac catheterization has been 
shcwn to provoke a diffuse reduction in the lumen of the left 
anterior descending artery, suggesting a direct vasoconstric- 
live effect of cigarette smoking (20). Furthermore, smokers 
with variant angina who are withdrawn from medical therapy 
have a higha incidence of recurrent angina than do nan- 
smokers 1?6l. 
Coronary artery spasm. This has been reported in arm- 
tomtcaliy normal coronary arteries (27). Interestingly. er- 
gonovine sometimes provokes spasm of a “normal” coro- 
nary artery, even when the remaining vessels have severe 
h*ed ~tenoses (28). However, coronary artery spasm most 
often occorr at the. site of an angiographically identifiable 
atherosclerotic lesion (18) and the plsque is thought to be an 
important substrate for spasm (19;. In a studv (8) of I.089 
cowcutive patients und&going coronary an&graphy and 
methergine provocative testing, spasm was superimposed on 
fixed atheros terntic lesions in 60% of the patients with a 
positive test. Our findings are similar, with 66% of the 
positive tests occurring in patients with an~ographi~lly 
evident coronary artery disease. 
Of the clinical descriptors of angina, rest angina has often 
been associated with a positive ergottwine test result. 
regardless of the degree of coronary atherosclerosis (3J.15). 
In contrast, our study f&xl to identify any angbtel charac- 
teristics that were associated with an increased likelihood of 
a positive test result; others (4.16) have also reported this 
lack of association. 
Ergonovine provocative testing at the time of cardiac 
cat!~eterization measures the vasomotility of the coronary 
arteries in response to the drug. Although a negative tes: 
result does not necessarily exclude coronary spasm (IS), if 
rigid criteria are followed, a positive result is often accepted 
as diagnostic of vasospastic angina (7). Although it is ac- 
cepted that coronary vasospasm after ergonovioe testing 
may bear no relation to the clinical attginal syndrome pre- 
sented by the patient, it does suggest that the coronary 
aneries are woreactive and that his increased vanaactivity 
call be demonstrated by such provocativs means as er- 
goonovine adnmistration. 
Conclusions. Ergonovme provoczive testmg in a lsrge 
group of patients without Priszmetal’s angina and with 
insignificant or ao coronxy artery disease UIS ansociarcd 
witb a very low incidence of complications, bur also a vzry 
low overa! rate of a punitive response. Two predictors of a 
positive test were identified using multwariate analysis: a 
history of smoking and the presence of a ~50% coronary 
xtew stenosis. Use of these vanab!es alluscd the identS- 
cation of a subser of 17% of tne study group with a IO% rate 
of a positivt test result. These data should allow clinicians 
who-use provocative testing in the cardiac cathererization 
laboratory to reserve testing for the rubse! of patients mwt 
likely to demonstrate vasospasm during ergonovine admic- 
is:rxion. 
